Companies108 Funding$41.6B Rounds77 ▼1 mo Investors75 Eng roles4338 ● updated moments ago
VIX The Intelligent Venture Terminal beta

Basecamp Research

current — rebuilt moments ago

Basecamp Research

☆ Watch

The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how. observed

fresh · evidence today 11 sources no confidence data
64.3/100
Venture signal
scored above 67% of growth peers
Outlook Stable
Why this score? ↓

What we have established three decisions, kept apart

  1. 1 Identity verified Not recorded

    No person- or entity-level identity check is on record for this company. A name match is not one.

  2. 2 Evidence sufficient to publish Yes

    The inclusion bar: two or more independent sourced evidence families. This profile is published and listed. It is a statement about how much evidence we hold, and about nothing else.

  3. 3 Fit for a seed/Series-A sourcing buyer Not a fit

    Evidence places this company outside this buyer’s market. The profile stays published; this labels it.

    POSITIVE MANDATE MISMATCH: the latest covered financing event carries a source-stated stage of series_c, beyond the frozen seed/Series-A mandate. Latest round resolved by the projection is series_c; no unlabelled event (e.g. a later Form D) is held that could supersede it. OVERTURN CONDITION: a source showing the latest financing event is actually seed/Series-A, or that the buyer mandate includes series_c. The verdict rests on the SOURCE-STATED stage "series_c", not on size, age or industry.

    Venture backing: not found · Stage band: series_c — stated by the held funding source (https://siliconangle.com/2026/09/23/ai-drug-discovery-startup-basecamp-research-raises-140m/), announced 2026-09-23

    What would overturn this:

    Assessed 2026-10-24 for seed/Series-A sourcing.

Funding
$140M
2026-09-23
Adoption
no signal
downloads / week
Developer
not scored
momentum / 100
Hiring
no board
eng openings
Commercial
sales-led
homepage

Composite signal v0 19 ±23 · 2 components

Five evidence lanes (activity, capital, infra, hiring, ecosystem) as within-cohort percentiles, combined with evidence-breadth weights over the 60-company baseline cohort. The ± band widens with missing lanes — it measures what the score stands on. 3 signals in the last 60 days back this number.

Traction

Current round

Opportunity & risk

↗ Strongest signal: funding_magnitude (20% of the score).

↓ Scored on 2 of 4 components — adoption, developer had no computable metric.

8 independent sources 0 promoted signals inspect the evidence →

The skeptic's read what this company has said, judged against what happened

6 claims on record 0 verified 0 contradicted 6 still unproven

Unproven ≠ false — it means the deadline or the evidence hasn't arrived. Nothing here is editorial: every count is a ledger row you can open on the Proof page.

Evaluation

How it's evaluated Four independent layers ▾

No single number decides. Layers can disagree — that's the point. New to this? →

Platform score derived
64/100
Founder self-assessment claimed
11/100
Investor ratings opinion
—
Expert ratings opinion
—
Rate this company Investor or expert role required ▾
—/5 · 0 investors

Sign in as an investor or expert to rate this company.
Technology No signals collected yet ▾
No technology data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Team & hiring No signals collected yet ▾
No team & hiring data yet. This category is part of the record and will populate as evidence is collected or the founder provides it.
Market & funding stage 1 of 3 signals present ▾
Funding stage
not provided
Lifecycle stage
not provided
Latest round stage
series_c observed
Timeline 1 events ▾
  1. 2026-09-23 series_c · $140M

Evidence & scoring

Why this score? none_required ▾

VentureSignalScore 64.3/100 for basecamp-research, composed from 2 of 4 components (emerging formula), discounted ×0.85 for 50% signal coverage

ComponentWeightNormalizedContribution
funding_recency 0.2 0.9048 0.181
funding_magnitude 0.3 0.6585 0.1975

Evidence this score rests on

Narrative vs. reality No SEC filing found for this round

Reported narrative · Tier 2
$140M series c
announced 2026-09-23 · source ↗
Filed reality · Tier 0 · SEC
No SEC Form D on record.

An evidence gap, not proof of falsity: Form D is not always required (foreign offerings, certain exemptions) or may not be filed yet.

Financing events four different events, four different dates

A first sale, a filing, an amendment and a public announcement are not the same event, and one date may not stand in for another. Where the latest financing date cannot be established from what we hold, this says unknown rather than substituting a date we do have.

Latest established financing date
2026-09-23
Money moved on or after
2026-09-23
Total reported by
not established
Basis
reported round

A reported round dated 2026-09-23 by its own source.

Community chatter Hacker News · Tier 3 · unverified manip. risk low · 0

Gray-market attention, not quality. 1+ HN mentions (peak 1 points). Claim-shaped headlines are rumors until corroborated — a Tier-3 factual claim carries no evidentiary weight on its own. ▲ 1 Scaling microbial metagenomic datasets (Basecamp Research) 2024-07-11 ↗

Raw observations 230 records ▾
AttributeValueKindSourceObservedStateConf.
ai.document.claims {"claims": [{"claim": "Basecamp Research has discovered over 100 billion novel genes from all 7 continents.", "quote": "Over 100 billion novel genes discovered from across all 7 continents.", "topic": observed artifact ↗ 2026-10-25 promoted 0.50
buyer_fit.assessment {"buyer": "seed/Series-A sourcing", "method": "Backlog pass 2026-10-24: applied the record_buyer_fit.ts fit rule to this company's held primary-source financing evidence (funding.round.* / sec.form_d. observed assessment 2026-10-24 normalized 0.90
buyer_fit.status not_a_fit observed assessment 2026-10-24 normalized 0.90
common_name Basecamp Research observed artifact ↗ 2026-09-28 normalized 0.90
common_name Basecamp Research observed artifact ↗ 2026-10-25 normalized 0.60
community.hn.max_points 314 observed artifact ↗ 2026-09-30 superseded 0.20
community.hn.max_points 1 observed artifact ↗ 2026-10-08 normalized 0.20
community.hn.mentions 11 observed artifact ↗ 2026-09-30 superseded 0.20
community.hn.mentions 1 observed artifact ↗ 2026-10-08 normalized 0.20
community.hn.rumors [] observed artifact ↗ 2026-09-30 normalized 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=41448439", "title": "Show HN: An open-source implementation of AlphaFold3", "points": 314, "created_at": "2024-09-04"} observed artifact ↗ 2024-09-04 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=40936878", "title": "Scaling microbial metagenomic datasets (Basecamp Research)", "points": 1, "created_at": "2024-07-11"} observed artifact ↗ 2024-07-11 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=40936878", "title": "Scaling microbial metagenomic datasets (Basecamp Research)", "points": 1, "created_at": "2024-07-11"} observed artifact ↗ 2024-07-11 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=40936878", "title": "Scaling microbial metagenomic datasets (Basecamp Research)", "points": 1, "created_at": "2024-07-11"} observed artifact ↗ 2024-07-11 superseded 0.20
community.hn.top_story {"url": "https://news.ycombinator.com/item?id=40936878", "title": "Scaling microbial metagenomic datasets (Basecamp Research)", "points": 1, "created_at": "2024-07-11"} observed artifact ↗ 2024-07-11 normalized 0.20
description The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how. observed artifact ↗ 2026-10-25 normalized 0.70
domain www.basecamp-research.com observed artifact ↗ 2026-10-25 normalized 0.95
funding.round.amount_usd 140000000 observed artifact ↗ 2026-09-23 normalized 0.90
funding.round.announced_on 2026-09-23 observed artifact ↗ 2026-09-23 normalized 0.90
funding.round.lead_investors [] observed artifact ↗ 2026-09-23 normalized 0.90
funding.round.source_url https://siliconangle.com/2026/09/23/ai-drug-discovery-startup-basecamp-research-raises-140m/ observed artifact ↗ 2026-09-23 normalized 0.90
funding.round.stage series_c observed artifact ↗ 2026-09-23 normalized 0.90
gate.accumulation {"outcome": "document_created", "obs_count": 15, "source_id": "01M5RSA71K2M4BHTS73TTH2V30", "trigger_path": "accumulation_gate", "collector_count": 3, "artifact_collector": "website_collector"} observed artifact ↗ 2026-10-25 normalized 0.60
metric.venture.funding_amount_usd 140000000 derived calc 2026-09-28 derived 0.90
metric.venture.funding_recency_days 5.9753 derived calc 2026-09-28 superseded 0.90
metric.venture.funding_recency_days 7.6428 derived calc 2026-09-30 superseded 0.90
metric.venture.funding_recency_days 7.6877 derived calc 2026-09-30 superseded 0.90
metric.venture.funding_recency_days 7.9589 derived calc 2026-09-30 superseded 0.90
metric.venture.funding_recency_days 8.3322 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 8.3827 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 8.4622 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 8.6166 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 8.7068 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 8.7739 derived calc 2026-10-01 superseded 0.90
metric.venture.funding_recency_days 15.8891 derived calc 2026-10-08 superseded 0.90
metric.venture.funding_recency_days 16.2923 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 16.3102 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 16.5208 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 16.7963 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 16.9398 derived calc 2026-10-09 superseded 0.90
metric.venture.funding_recency_days 17.0267 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.1147 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.2018 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.2956 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.4069 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.4943 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.5918 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.6795 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.7677 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.8217 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 17.9098 derived calc 2026-10-10 superseded 0.90
metric.venture.funding_recency_days 18.0094 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.0975 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.1081 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.1086 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.1278 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.2099 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.3109 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.3664 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.4067 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.496 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.5859 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.6752 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.7655 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.8572 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 18.9467 derived calc 2026-10-11 superseded 0.90
metric.venture.funding_recency_days 19.0402 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.0605 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.0809 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.1243 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.1963 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.9508 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 19.9788 derived calc 2026-10-12 superseded 0.90
metric.venture.funding_recency_days 20.0286 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 20.082 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 20.1719 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 20.262 derived calc 2026-10-13 superseded 0.90
metric.venture.funding_recency_days 21.275 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.3658 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.4569 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.5664 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.6615 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.7586 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.8537 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 21.9489 derived calc 2026-10-14 superseded 0.90
metric.venture.funding_recency_days 22.0461 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.1415 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.2368 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.2969 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.3931 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.4886 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.6013 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.6968 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.7952 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.8913 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.9873 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 22.9892 derived calc 2026-10-15 superseded 0.90
metric.venture.funding_recency_days 23.0854 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.1816 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.2801 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.3451 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.3775 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.4743 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 23.5733 derived calc 2026-10-16 superseded 0.90
metric.venture.funding_recency_days 25.5943 derived calc 2026-10-18 superseded 0.90
metric.venture.funding_recency_days 25.691 derived calc 2026-10-18 superseded 0.90
metric.venture.funding_recency_days 26.0809 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.1776 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.28 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.3823 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.4799 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.5946 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.6915 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.7884 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.8855 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 26.9827 derived calc 2026-10-19 superseded 0.90
metric.venture.funding_recency_days 27.0813 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.1134 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.2128 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.313 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.4143 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.5299 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.6292 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.944 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 27.9841 derived calc 2026-10-20 superseded 0.90
metric.venture.funding_recency_days 28.0487 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.1464 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.2407 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.3107 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.3634 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.4135 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.5179 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.6167 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.716 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.815 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 28.9139 derived calc 2026-10-21 superseded 0.90
metric.venture.funding_recency_days 29.021 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.12 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.2192 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.3207 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.4201 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.5366 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.6361 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.7358 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.8391 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 29.9388 derived calc 2026-10-22 superseded 0.90
metric.venture.funding_recency_days 30.0386 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.1384 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.2386 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.3455 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.358 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.4582 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.5644 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.6648 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.7683 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.7988 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.8651 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 30.9655 derived calc 2026-10-23 superseded 0.90
metric.venture.funding_recency_days 31.0555 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.1276 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.1559 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.2466 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.4343 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.5462 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.6472 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.7484 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.8494 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 31.9506 derived calc 2026-10-24 superseded 0.90
metric.venture.funding_recency_days 32.0521 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.1533 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.2363 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.2385 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.2552 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.3565 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.4584 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.5617 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.6633 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.765 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.8666 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 32.9686 derived calc 2026-10-25 superseded 0.90
metric.venture.funding_recency_days 33.0708 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.1727 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.275 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.377 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.4799 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.5922 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.6945 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.7974 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 33.9 derived calc 2026-10-26 superseded 0.90
metric.venture.funding_recency_days 34.0026 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.1051 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.2076 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.3123 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.4149 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.5255 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.6285 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.7316 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.8347 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 34.9377 derived calc 2026-10-27 superseded 0.90
metric.venture.funding_recency_days 35.0409 derived calc 2026-10-28 superseded 0.90
metric.venture.funding_recency_days 35.1441 derived calc 2026-10-28 superseded 0.90
metric.venture.funding_recency_days 35.2474 derived calc 2026-10-28 superseded 0.90
metric.venture.funding_recency_days 35.3506 derived calc 2026-10-28 superseded 0.90
metric.venture.funding_recency_days 35.454 derived calc 2026-10-28 derived 0.90
score.venture_signal 67 derived calc 2026-09-28 superseded 0.60
score.venture_signal 66.9 derived calc 2026-09-30 superseded 0.60
score.venture_signal 66.8 derived calc 2026-09-30 superseded 0.60
score.venture_signal 66.1 derived calc 2026-10-08 superseded 0.60
score.venture_signal 66 derived calc 2026-10-09 superseded 0.60
score.venture_signal 65.9 derived calc 2026-10-10 superseded 0.60
score.venture_signal 65.8 derived calc 2026-10-11 superseded 0.60
score.venture_signal 65.7 derived calc 2026-10-12 superseded 0.60
score.venture_signal 65.6 derived calc 2026-10-14 superseded 0.60
score.venture_signal 65.5 derived calc 2026-10-14 superseded 0.60
score.venture_signal 65.4 derived calc 2026-10-15 superseded 0.60
score.venture_signal 65.2 derived calc 2026-10-18 superseded 0.60
score.venture_signal 65.1 derived calc 2026-10-19 superseded 0.60
score.venture_signal 65 derived calc 2026-10-20 superseded 0.60
score.venture_signal 64.9 derived calc 2026-10-21 superseded 0.60
score.venture_signal 64.8 derived calc 2026-10-22 superseded 0.60
score.venture_signal 64.7 derived calc 2026-10-23 superseded 0.60
score.venture_signal 64.6 derived calc 2026-10-24 superseded 0.60
score.venture_signal 64.5 derived calc 2026-10-25 superseded 0.60
score.venture_signal 64.4 derived calc 2026-10-26 superseded 0.60
score.venture_signal 64.3 derived calc 2026-10-27 derived 0.60
sector emerging derived calc 2026-10-01 normalized 0.50
source.document.reference {"kind": "document", "title": "basecamp-research: Basecamp Research | Frontier AI models for therapeutic design", "source_id": "01M5RSA71K2M4BHTS73TTH2V30", "extract_ref": "artifact:sha256:31c3a39e5c5 observed artifact ↗ 2026-10-25 normalized 0.95
website_url https://www.basecamp-research.com observed enrichment 2026-10-25 normalized 0.75
website_url https://www.basecamp-research.com observed artifact ↗ 2026-10-25 normalized 0.95
website.homepage.has_pricing_link false observed artifact ↗ 2026-10-25 normalized 0.80